RAC 2.73% $1.61 race oncology ltd

General Comments / Chat, page-2418

  1. 67 Posts.
    lightbulb Created with Sketch. 13
    Thought this slide was interesting from another Phase 2 therapeutic company in collaboration with Merck. In a way demonstrating the opportunity ahead for RAC, well that's how I viewed the slide anyway.

    https://hotcopper.com.au/data/attachments/3040/3040174-86b4e703e1556b6cf5e418f1359ec718.jpg
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.